Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of new‐onset type 2 diabetes in 600 055 people after COVID‐19: A cohort study
Morgan Birabaharan, David C. Kaelber, Jeremy Pettus, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 6, pp. 1176-1179
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis
Ting Zhang, Qimin Mei, Zhaocai Zhang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 113
Long COVID: An inevitable sequela of SARS-CoV-2 infection
Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 1, pp. 1-9
Open Access | Times Cited: 98
Association of COVID-19 Infection With Incident Diabetes
Zaeema Naveed, Héctor Alexander Velásquez García, Stanley Wong, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238866-e238866
Open Access | Times Cited: 53
Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza
Justin Y. Lu, Jack Wilson, Wei Hou, et al.
EBioMedicine (2023) Vol. 90, pp. 104487-104487
Open Access | Times Cited: 44
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis
Mainak Banerjee, Rimesh Pal, Sulagna Dutta
Primary care diabetes (2022) Vol. 16, Iss. 4, pp. 591-593
Open Access | Times Cited: 54
Diabetes and COVID-19: Short- and Long-Term Consequences
Charlotte Steenblock, Mohamed Hassanein, Emran G. Khan, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 08, pp. 503-509
Open Access | Times Cited: 50
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis
Honghao Lai, Manli Yang, Mingyao Sun, et al.
Metabolism (2022) Vol. 137, pp. 155330-155330
Open Access | Times Cited: 39
Risk of New-Onset Diabetes Mellitus as a Post-COVID-19 Condition and Possible Mechanisms: A Scoping Review
Prabal Chourasia, Lokesh Goyal, Dhruv Kansal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1159-1159
Open Access | Times Cited: 25
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis
Jiajun Li, Yapeng Li, Zhenzhen Wang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 25
Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study
A Xu, Stephen Wang, Timothy Q. Duong
BMJ Open Diabetes Research & Care (2023) Vol. 11, Iss. 3, pp. e003257-e003257
Open Access | Times Cited: 23
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Rachel Wong, Emily K.Y. Lam, Carolyn T. Bramante, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 8, pp. 207-216
Open Access | Times Cited: 20
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
The rise in incidence of pediatric type 2 diabetes during the COVID-19 pandemic and the virus as a potential causative factor
Andrew Kanouse, Joanna Fishbein, Parissa Salemi
Diabetes Epidemiology and Management (2025), pp. 100258-100258
Open Access
HINT2 may be One Clinical Significance Target for Patient with Diabetes Mellitus and Reduced ROS-Induced Oxidative Stress and Ferroptosis by MCU
Mei Bai, Wei Lu, Jun Tan, et al.
Hormone and Metabolic Research (2024) Vol. 56, Iss. 09, pp. 670-678
Closed Access | Times Cited: 3
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 3
Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2
Sundararaj Stanleyraj Jeremiah, Abu Saleh Md Moin, Alexandra E. Butler
Metabolism (2024) Vol. 156, pp. 155917-155917
Closed Access | Times Cited: 3
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Cristina Bică, Teodor Salmen, et al.
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 33-60
Open Access | Times Cited: 8
COVID-19 and Rising Incidence of Diabetes: Despite Evolving Data, an Enigma Still to Be Solved
William T. Cefalu
Diabetes Care (2023) Vol. 46, Iss. 5, pp. 913-915
Open Access | Times Cited: 7
Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial
Matthias Hepprich, Jonathan M. Mudry, Claudia Gregoriano, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101649-101649
Open Access | Times Cited: 10
Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study
Celina Gollop, Rebecca Zingel, Louis Jacob, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 1033-1040
Open Access | Times Cited: 5
Diabetes following SARS-CoV-2 infection: Incidence, persistence, and implications of COVID-19 vaccination. A cohort study of fifteen million people
Kurt Taylor, Sophie V. Eastwood, Venexia Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
COVID-19 infection and incident diabetes in American Indian and Alaska Native people: a retrospective cohort study
James W. Keck, Mary E. Lacy, Sara Bressler, et al.
The Lancet Regional Health - Americas (2024) Vol. 33, pp. 100727-100727
Open Access | Times Cited: 1
Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes: A target trial emulation study
Eric Yuk Fai Wan, Zoey C. T. Wong, Vincent Ka Chun Yan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4653-4664
Closed Access | Times Cited: 1
Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review
Irena Ilić, Milena Ilić
Life (2023) Vol. 13, Iss. 6, pp. 1233-1233
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top